Publication | Closed Access

Synergistic anti-tumor effects of combined gemcitabine and cisplatin nanoparticles in a stroma-rich bladder carcinoma model

NanomedicineUrologyOncologyCisplatin NanoparticlesGenitourinary CancerMedicineTumor TargetingCombined GemcitabineSynergistic Anti-tumor EffectsCancer TreatmentAnti-cancer AgentPharmacologyTumor MicroenvironmentTumor Biology